Skip to main content

Table 1 Admission Blood Counts and Liver Function Testing

From: Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge

 

Admission

3 weeks prior to admission

Normal range

White Blood Cell (WBC)

3.37

6.69

4.8–10.8 K/cumm

Hemoglobin

9.5

12.6

14–18 g/dL

Platelets

32

195

140–440 K/cumm

Aspartate Aminotransferase (AST)

289

20

5–34 U/L

Alanine Aminotransferase (ALT)

474

20

5–45 U/L

Alkaline Phosphatase (ALP)

474

76

35–150 U/L

Total Bilirubin

1.8

0.5

0.2–1.2 mg/dL